Leco (Michigan, USA) will support the new West Coast Metabolomics Center, based at the University of California, Davis, Genome Center (California, USA).
Leco (Michigan, USA) will support the new West Coast Metabolomics Center, based at the University of California, Davis, Genome Center (California, USA). The center was opened on 8th October 2012, with funding of $9.3 million from the National Institute of Health and Disease.
Directed by Oliver Fiehn, Professor of Molecular and Cellular Biology at UC Davis, the center aims to advance research into understanding and developing treatments for diseases including diabetes, cancer and atherosclerosis using metabolomics. Metabolism differs from person to person and different dosage levels for drugs are required. As part of this support, Leco will provide access to liquid chromatography-high resolution time-of-flight mass spectrometry (LC–HR–TOF) instrumentation.
“This partnership demonstrates LECO’s renewed commitment to the advancement of metabolomics,” said Dr. Jeff Patrick, Director of Marketed Technology, LECO Separation Science. Patrick added that Leco were honoured that Dr. Fiehn and his team chose Leco instrumentation for the West Coast Metabolomics Center and his company was excited about the implications their research will have on the treatment of certain diseases.
For more information, please visit:
www.leco.com
Inside the Laboratory: The Gionfriddo Group at the University at Buffalo
March 28th 2024In this edition of “Inside the Laboratory,” Emanuela Gionfriddo, PhD, an associate professor of chemistry at the University at Buffalo, discusses her group’s current research endeavors, including using solid-phase microextraction (SPME) coupled to liquid chromatography (LC) and gas chromatography (GC) to further understand the chemical relationship between environmental exposure and disease and elucidate micropollutants fate in the environment and biological systems.
Transferring Methods to Compact and Portable HPLC
February 14th 2024The current trend in laboratory equipment design is the miniaturization of laboratory instruments. Smaller-scale HPLC instruments offer benefits that cannot be matched by analytical-scale equipment, especially in the areas of portability, reduced fluid volumes, and reduced operating costs. Yet, the miniaturization of laboratory equipment has brought with it a unique set of challenges, including transferring methods to compact LC. Capillary LC expands the use of LC to applications not currently done using conventional LC in a wide array of application areas, including pharmaceutical, food and beverage, petrochemical, environmental, and oil and gas. Greg Ward, Axcend’s CEO wrote, “Customers want an HPLC system with a small footprint, low flow rates and green chemistry.” Join his podcast where he shares method transfer in these application areas.